Celebrating the achievements of IU pediatric research program

The Department of Pediatrics at Indiana University School of Medicine continues to improve the lives of families in Indiana and beyond through its world-class pediatric research program, a collaboration with Riley Children’s Health. Now ranked seventh in the nation in National Institutes of Health funding, the department is home to the only nationally ranked pediatric research program in Indiana and the top-ranked program in the Midwest.

In federal fiscal year 2022, IU pediatric physician scientists received a record $38 million in NIH funding, a 9 percent increase from the previous year. The IU-led research supported by these funds also helps ensure Riley Hospital for Children at IU Health remains among the top children’s hospitals in the nation.

These remarkable achievements reflect the intentional work and transformative research of IU faculty, who revolutionize the care provided to Hoosiers and individuals across the globe. For example, Dr. Seethal Jacob is leveraging telemedicine to enhance care for children with sickle cell disease in underserved communities. Dr. Roland W. Herzog is investigating gene therapy as a safe and lasting cure for kids with hemophilia. Research from Dr. Carmella Evans-Molina contributed to a new drug that delays the onset of Type 1 diabetes in at-risk children and adults. Dr. Benjamin Gaston has developed new medications for children with severe asthma and is leading a national group testing the therapies for safety and effectiveness.

Congratulations to Department of Pediatrics Chair Dr. Wade Clapp, IU School of Medicine Dean Dr. Jay Hess, and all of the pediatric researchers and physicians at IU for their continued dedication to improving children's lives. 

Pamela Whitten

President
Indiana University